Boniva is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Ibandronate Sodium.
| Product ID | 0004-0191_20b76315-bc0f-40d2-b877-a1df6e3e2461 |
| NDC | 0004-0191 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Boniva |
| Generic Name | Ibandronate Sodium |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2006-01-06 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021858 |
| Labeler Name | Genentech, Inc. |
| Substance Name | IBANDRONATE SODIUM |
| Active Ingredient Strength | 3 mg/3mL |
| Pharm Classes | Bisphosphonate [EPC],Diphosphonates [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2006-01-06 |
| Marketing End Date | 2021-06-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021858 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2006-01-06 |
| Ingredient | Strength |
|---|---|
| IBANDRONATE SODIUM | 3 mg/3mL |
| SPL SET ID: | 5500be0f-8b29-450c-9857-755029965157 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0004-0186 | Boniva | ibandronate sodium |
| 0004-0191 | Boniva | ibandronate sodium |
| 23155-162 | Ibandronate sodium | Ibandronate sodium |
| 25021-827 | ibandronate sodium | ibandronate sodium |
| 33342-150 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
| 47781-103 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
| 51224-008 | IBANDRONATE SODIUM | Ibandronate Sodium |
| 55111-575 | Ibandronate sodium | Ibandronate sodium |
| 55150-191 | Ibandronate Sodium | Ibandronate Sodium |
| 60429-643 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
| 60505-2795 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
| 60505-6097 | Ibandronate Sodium | ibandronate sodium |
| 62756-218 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
| 65862-237 | Ibandronate Sodium | Ibandronate Sodium |
| 67457-524 | ibandronate sodium | ibandronate sodium |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() BONIVA 78404853 not registered Dead/Abandoned |
Roche Therapeutics Inc. 2004-04-20 |
![]() BONIVA 78392767 not registered Dead/Abandoned |
Boniva Software, Inc. 2004-03-29 |
![]() BONIVA 78209524 2931724 Live/Registered |
Roche Therapeutics Inc. 2003-01-31 |